Furthermore, bone metastatic breast cancer cells selected via successive injections and recovery from the bone display upregulated CXCR4 compared to the parental cell lines, suggesting that bone metastatic tumor cells acquire the expression of CXCR4 that facilitates the homing towards the CXCL12 at the niche [113]. This evidence concerns the gene CXCL12 and neoplasm.